[1. Wingard JR. Importance of candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis Jan 1995; 20 (1):115-25. doi: http://dx.doi.org/10.1093/clinids/20.1.11510.1093/clinids/20.1.115]Ouvrir le DOISearch in Google Scholar
[2. Calderon RA, Fonzi WA. Virulence factor of Candida albicans. Trends Microbiol 2001; 327-335. doi: http://dx.doi.org/10.1016/S0966-842X(01)02094-710.1016/S0966-842X(01)02094-7]Ouvrir le DOISearch in Google Scholar
[3. Singh N. Trends in the epidemiology of opportunistic fungal infections: predisposing factors of antimicrobial use practices (Review article). Clin Infect Dis 2001; 33:1692-1696. doi: http://dx.doi.org/10.1086/32389510.1086/323895]Ouvrir le DOISearch in Google Scholar
[4. Samaranayake LP. Oral mycoses in HIV infection. Oral Med Oral Pathol 1992; 73: 171-180. doi: http://dx.doi.org/10.1016/0030-4220(92)90191-R10.1016/0030-4220(92)90191-]Ouvrir le DOISearch in Google Scholar
[5. Dignani MC, Solomkin JS, Anaissie EJ, Candida. In: Anaissie EJ, McGinnis MR, Pfaller MA. Clinical Mycology. Churchill Livingstone 2003:195-239.]Search in Google Scholar
[6. Samaranayake LP, Lamey PJ. Oral candidosis: 1. Clinicopathological aspects. Dent Update 1988; 15:227-228, 230-231.]Search in Google Scholar
[7. Mac Phail LM, Green Span D, Dodd CL, Heinic GS, Beck C, Ekoku E. Association of fungal species with oral candidiasis in HIV infection. J Dent Res 1993; 72:353.]Search in Google Scholar
[8. Samaranayake YH, Samaranayake LP. Experimental oral candidiasis in animal models. J Clin Microbiol 2001; 14: 398-429. doi: http://dx.doi.org/10.1128/CMR.14.2.398-429.200110.1128/CMR.14.2.398-429.20018898111292645]Search in Google Scholar
[9. Ellepolla A N B, Samaranayake LP. Oral candidal infections and antimycoties. Crit Rev Oral Biol Med 2000; 11:172-198.10.1177/1045441100011002030112002814]Ouvrir le DOISearch in Google Scholar
[10. Kauffman CA, Carver PL. Antifungal agents in the 1990s. Current status and future developments. Drugs 1997; 53:539-549. doi: http://dx.doi.org/10.2165/00003495-199753040-0000110.2165/00003495-199753040-000019098658]Search in Google Scholar
[11. Ahmad S, Khan Z, Mustafa AS, Khan ZU. Semi-nested PCR for diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for species identification. J Clin Microbiol 2002; 40(7):2483-2489. doi: http://dx.doi.org/10.1128/JCM.40.7.2483-2489.200210.1128/JCM.40.7.2483-2489.200212053512089267]Ouvrir le DOISearch in Google Scholar
[12. Ghasemi Dehkordi N. Iranian Herbal Pharmacopoeia (IHP). Min Health Pub 2002; 2:749-753.]Search in Google Scholar
[13. Abdollahi M, Salehnia A, Mortazavi SH, Ebrahimi M, Shafiee A, Fouladian F, et al. Antioxidant, antidiabetic, antihyperlipidemic, reproduction stimulatory properties and safety of essential oil of Satureja khuzestanica in rat in vivo: a toxicopharmacological study. Med Sci Monit 2003; 9: BR331-335.]Search in Google Scholar
[14. Amanlou M, Fazeli MR, Arvin A, Amin HG, Farsam H. Antimicrobial activity of crude methanolic extract of Satureja khuzestanica. Fitoterapia 2004; 75:768-770.10.1016/j.fitote.2004.09.00515567261]Ouvrir le DOISearch in Google Scholar
[15. Radpour M. Identification and structure of native and cultivated Satureja khuzestanica using GC-MS. Professional Doctorate Thesis, Faculty of Pharmacy, Teheran University of Medical Sciences, Thesis No. 4261, 2002.]Search in Google Scholar
[16. National committee for clinical laboratories standard. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. National committee clinical laboratories standard, 1997.]Search in Google Scholar
[17. Evans EGV, Richardson MD. Medical mycology. A practical approach. Oxford 1989.]Search in Google Scholar
[18. Chami N, Chami F, Bennis S, Trouillas J, Remmal A. Antifungal treatment with carvacrol and eugenol of oral candidiasis in immunosup-pressed rats. Braz Infect Dis 2004; 8:217-26. doi: http://dx.doi.org/S1413-8670200400030000510.1590/S1413-8670200400030000515476054]Search in Google Scholar
[19. Martinez A, Ferrer S, Santos I, Jimenez E, Sparrowe J, Regadera J, et al. Antifungal activities of two new Azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats. Antimicrob Agents Chemother 2001; 45:3304-3309. doi: http://dx.doi.org/10.1128/AAC.45.12.3304-3309.200110.1128/AAC.45.12.3304-3309.2001]Ouvrir le DOISearch in Google Scholar
[20. Martinez A, Regardera J, Jimenez E, Santos I, Gargallo-Viola D. Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats. Antimicrob Agents Chemother 2001; 45:1008-1013. doi: http://dx.doi.org/10.1128/AAC.45.4.1008-1013.200110.1128/AAC.45.4.1008-1013.2001]Search in Google Scholar
[21. Üner A, Nceboz T, Uysalci M, Dagci H. Immune deficiency and cryptosporidiosis in rats. Turk J Vet Anim Sci 2003; 27:1187-1191.]Search in Google Scholar
[22. Sepahvand A. Effects of antifungal Satureja Khuzestanika using in vitro in Lorestan province. MS, Faculty of Health and Institute for Health Research, Tehran University of Medical Sciences, Thesis No. 5348, 2004.]Search in Google Scholar
[23. Ultee A, Kets EPW, Smid ET. Mechanism of action of carvacrol on the food borne pathogen Bacillus cereus. Appl Environ Microbiol 1999; 65:4606-4610.10.1128/AEM.65.10.4606-4610.1999]Search in Google Scholar
[24. Amin GH, Salehi MH, Zahedi M, Khanavi M, Samadi N. Essential oil composition and antimicrobial activity of Oliveria decumbens. Fitoterapia 2005; 76:704-707.10.1016/j.fitote.2005.06.009]Ouvrir le DOISearch in Google Scholar
[25. Braga PC, Alfieri M, Culici M, Dal Sasso M. Inhibitory activity of thymol against the formation and viability of Candida albicans hyphae. Mycoses 2007; 50:502-506. doi: http://dx.doi.org/10.1111/j.1439-0507.2007.01412.x10.1111/j.1439-0507.2007.01412.x]Ouvrir le DOISearch in Google Scholar
[26. Manohar V, Ingram C, Gray J, Tlpur NA, Echarad BW, Bagchi D et al. Antifungal activities of origanum oil against Candida albicans. Mol Cell Biochem 2001; 228:111-117. doi: http://dx.doi.org/10.1023/A:101331163220710.1023/A:1013311632207]Ouvrir le DOISearch in Google Scholar
[27. Cosentino S, Tuberose CIG, Pishao B, Satta M, Mascia V, Arzedi E, Palmas F. In vitro antimicrobial activity and chemical composition of Thymus sardinian essential oils. Lett Appl Microbiol 1999; 29:130-135. doi: http://dx.doi.org/10.1046/j.1472-765X.1999.00605.x10.1046/j.1472-765X.1999.00605.x]Ouvrir le DOISearch in Google Scholar
[28. Grainger W, Presteril E, Schneeweiss B, Teleky B, Georgopoulos A. Treatment of Candida albi-cans fungamia with fluconazole. J Infect 1993; 26:133-146.10.1016/0163-4453(93)92761-K]Search in Google Scholar
[29. Russell C, Jones J. Effects of oral inoculation of Candida albicans in tetracycline-treated rats. J Med Microbiol 1973; 6:275-279.10.1099/00222615-6-3-2754580060]Search in Google Scholar
[30. Kimura LH, Pearsall NN. Relationship between germination of Candida albicans and increased adherence to buccal epithelial cells. Infect Immun 1980; 28:464-468.10.1128/iai.28.2.464-468.19805509586995309]Search in Google Scholar
[31. Martinez MV, Craig GT, Lamb DJ. An investigation of the role of true hypha production in the pathogenesis of experimental oral candidiosis. Sabouraudia 1984; 22:471-476.10.1080/003621784853807416395374]Ouvrir le DOISearch in Google Scholar
[32. Odds FC. Candida and candidiasis. Leicester 1979.]Search in Google Scholar
[33. Winner HI, Hurley R. Candida albicans. London 1964.]Search in Google Scholar
[34. O’Grady JF, Reade PC. Role of thermal trauma in experimental oral mucosal candida infection in rat. J Oral Pathol Med 1993; 22: 132-137. doi: http://dx.doi.org/10.1111/j.1600-0714.1993.tb01044.x10.1111/j.1600-0714.1993.tb01044.x8487219]Ouvrir le DOISearch in Google Scholar
[35. Arvin A. Phytochemistry, typography and study of effects of antimicrobial and antifungal Satureja khuzestanika. Indigenous and cultivated. Professional Doctorate Thesis, Faculty of Pharmacy, Tehran University of Medical Sciences, Thesis No. 4360, 2002-82.]Search in Google Scholar